What is INCR stock price today?

INCR (Intercure Ltd) stock is trading at $0.75 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is INCR stock going up or down today?

INCR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy INCR stock now?

The decision to buy INCR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is INCR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for INCR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is INCR stock overvalued or undervalued?

Use our DCF valuation calculator to determine if INCR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is INCR's P/E ratio?

P/E ratio data for INCR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is INCR's market cap?

INCR (Intercure Ltd) has a market capitalization of $0.04 billion, making it a small-cap stock.

What is INCR's price to book ratio?

INCR trades at a price-to-book (P/B) ratio of 0.29, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does INCR pay dividends?

INCR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is INCR's dividend yield?

INCR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is INCR stock a good long-term investment?

INCR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is INCR's revenue growth rate?

INCR has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

INCR is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in INCR?

Key risks for INCR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does INCR compare to its competitors?

Compare INCR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize INCR's performance and positioning.

What is INCR's stock price target for 2026?

Our AI model provides price targets for INCR based on fundamental analysis: Bull case $0.97 (+30%), Base case $0.86 (+15%), Bear case $0.67 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about INCR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for INCR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is INCR's next earnings report?

INCR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

INCR - Intercure Ltd

NYSE * Health Care * Pharmaceuticals

$0.75

$-0.01 (-1.49%)

About Intercure Ltd

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

INCR Key Statistics

Market Cap

$41.56M

P/B Ratio

0.29

EPS

$-0.51

Revenue Growth

+0.0%

Profit Margin

-0.3%

Employees

320

How INCR Compares to Peers

INCR is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
INCR(This stock)	$41.56M	N/A	0%	-0.3%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Intercure Ltd Company Information

Headquarters: Israel
Website: www.intercure.co
Sector: Health Care
Industry: Pharmaceuticals

Data Updated: April 16, 2026 at 5:27 PM EDT

Ready to invest in INCR?

Commission-free trading available. Affiliate links.

Upcoming Events for INCR

Dashboard

Enter a ticker to analyze